Click for best price
Transdermal Transmucosal Drug Delivery Market Size, Share 2022
When injections and pills are counter-indicated, transdermal and transmucosal delivery systems may get drugs into the body with great efficacy and beneficial results.
This report contains market size and forecasts of Transdermal and Transmucosal Drug Delivery in Global, including the following market information:
Global Transdermal and Transmucosal Drug Delivery Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Transdermal and Transmucosal Drug Delivery market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Transdermal Drug Delivery Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Transdermal and Transmucosal Drug Delivery include 3M, Antares Pharma, Aveva Drug Delivery Systems, Corium International, DURECT, Pantec Biosolutions, Tapemark and Tesa Labtec, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Transdermal and Transmucosal Drug Delivery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Transdermal and Transmucosal Drug Delivery Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Transdermal and Transmucosal Drug Delivery Market Segment Percentages, by Type, 2021 (%)
Transdermal Drug Delivery
Transmucosal Drug Delivery
Global Transdermal and Transmucosal Drug Delivery Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Transdermal and Transmucosal Drug Delivery Market Segment Percentages, by Application, 2021 (%)
Clinics
Hospitals
Others
Global Transdermal and Transmucosal Drug Delivery Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Transdermal and Transmucosal Drug Delivery Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Transdermal and Transmucosal Drug Delivery revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Transdermal and Transmucosal Drug Delivery revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
3M
Antares Pharma
Aveva Drug Delivery Systems
Corium International
DURECT
Pantec Biosolutions
Tapemark
Tesa Labtec
| Report Attributes |
Report Details |
| Report Title |
Transdermal and Transmucosal Drug Delivery Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Transdermal and Transmucosal Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Transdermal and Transmucosal Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Transdermal and Transmucosal Drug Delivery Overall Market Size
2.1 Global Transdermal and Transmucosal Drug Delivery Market Size: 2021 VS 2028
2.2 Global Transdermal and Transmucosal Drug Delivery Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Transdermal and Transmucosal Drug Delivery Players in Global Market
3.2 Top Global Transdermal and Transmucosal Drug Delivery Companies Ranked by Revenue
3.3 Global Transdermal and Transmucosal Drug Delivery Revenue by Companies
3.4 Top 3 and Top 5 Transdermal and Transmucosal Drug Delivery Companies in Global Market, by Revenue in 2021
3.5 Global Companies Transdermal and Transmucosal Drug Delivery Product Type
3.6 Tier 1, Tier 2 and Tier 3 Transdermal and Transmucosal Drug Delivery Players in Global Market
3.6.1 List of Global Tier 1 Transdermal and Transmucosal Drug Delivery Companies
3.6.2 List of Global Tier 2 and Tier 3 Transdermal and Transmucosal Drug Delivery Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Transdermal and Transmucosal Drug Delivery Market Size Markets, 2021 & 2028
4.1.2 Transdermal Drug Delivery
4.1.3 Transmucosal Drug Delivery
4.2 By Type - Global Transdermal and Transmucosal Drug Delivery Revenue & Forecasts
4.2.1 By Type - Global Transdermal and Transmucosal Drug Delivery Revenue, 2017-2022
4.2.2 By Type - Global Transdermal and Transmucosal Drug Delivery Revenue, 2023-2028
4.2.3 By Type - Global Transdermal and Transmucosal Drug Delivery Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Transdermal and Transmucosal Drug Delivery Market Size, 2021 & 2028
5.1.2 Clinics
5.1.3 Hospitals
5.1.4 Others
5.2 By Application - Global Transdermal and Transmucosal Drug Delivery Revenue & Forecasts
5.2.1 By Application - Global Transdermal and Transmucosal Drug Delivery Revenue, 2017-2022
5.2.2 By Application - Global Transdermal and Transmucosal Drug Delivery Revenue, 2023-2028
5.2.3 By Application - Global Transdermal and Transmucosal Drug Delivery Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Transdermal and Transmucosal Drug Delivery Market Size, 2021 & 2028
6.2 By Region - Global Transdermal and Transmucosal Drug Delivery Revenue & Forecasts
6.2.1 By Region - Global Transdermal and Transmucosal Drug Delivery Revenue, 2017-2022
6.2.2 By Region - Global Transdermal and Transmucosal Drug Delivery Revenue, 2023-2028
6.2.3 By Region - Global Transdermal and Transmucosal Drug Delivery Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Transdermal and Transmucosal Drug Delivery Revenue, 2017-2028
6.3.2 US Transdermal and Transmucosal Drug Delivery Market Size, 2017-2028
6.3.3 Canada Transdermal and Transmucosal Drug Delivery Market Size, 2017-2028
6.3.4 Mexico Transdermal and Transmucosal Drug Delivery Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Transdermal and Transmucosal Drug Delivery Revenue, 2017-2028
6.4.2 Germany Transdermal and Transmucosal Drug Delivery Market Size, 2017-2028
6.4.3 France Transdermal and Transmucosal Drug Delivery Market Size, 2017-2028
6.4.4 U.K. Transdermal and Transmucosal Drug Delivery Market Size, 2017-2028
6.4.5 Italy Transdermal and Transmucosal Drug Delivery Market Size, 2017-2028
6.4.6 Russia Transdermal and Transmucosal Drug Delivery Market Size, 2017-2028
6.4.7 Nordic Countries Transdermal and Transmucosal Drug Delivery Market Size, 2017-2028
6.4.8 Benelux Transdermal and Transmucosal Drug Delivery Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Transdermal and Transmucosal Drug Delivery Revenue, 2017-2028
6.5.2 China Transdermal and Transmucosal Drug Delivery Market Size, 2017-2028
6.5.3 Japan Transdermal and Transmucosal Drug Delivery Market Size, 2017-2028
6.5.4 South Korea Transdermal and Transmucosal Drug Delivery Market Size, 2017-2028
6.5.5 Southeast Asia Transdermal and Transmucosal Drug Delivery Market Size, 2017-2028
6.5.6 India Transdermal and Transmucosal Drug Delivery Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Transdermal and Transmucosal Drug Delivery Revenue, 2017-2028
6.6.2 Brazil Transdermal and Transmucosal Drug Delivery Market Size, 2017-2028
6.6.3 Argentina Transdermal and Transmucosal Drug Delivery Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Transdermal and Transmucosal Drug Delivery Revenue, 2017-2028
6.7.2 Turkey Transdermal and Transmucosal Drug Delivery Market Size, 2017-2028
6.7.3 Israel Transdermal and Transmucosal Drug Delivery Market Size, 2017-2028
6.7.4 Saudi Arabia Transdermal and Transmucosal Drug Delivery Market Size, 2017-2028
6.7.5 UAE Transdermal and Transmucosal Drug Delivery Market Size, 2017-2028
7 Players Profiles
7.1 3M
7.1.1 3M Corporate Summary
7.1.2 3M Business Overview
7.1.3 3M Transdermal and Transmucosal Drug Delivery Major Product Offerings
7.1.4 3M Transdermal and Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.1.5 3M Key News
7.2 Antares Pharma
7.2.1 Antares Pharma Corporate Summary
7.2.2 Antares Pharma Business Overview
7.2.3 Antares Pharma Transdermal and Transmucosal Drug Delivery Major Product Offerings
7.2.4 Antares Pharma Transdermal and Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.2.5 Antares Pharma Key News
7.3 Aveva Drug Delivery Systems
7.3.1 Aveva Drug Delivery Systems Corporate Summary
7.3.2 Aveva Drug Delivery Systems Business Overview
7.3.3 Aveva Drug Delivery Systems Transdermal and Transmucosal Drug Delivery Major Product Offerings
7.3.4 Aveva Drug Delivery Systems Transdermal and Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.3.5 Aveva Drug Delivery Systems Key News
7.4 Corium International
7.4.1 Corium International Corporate Summary
7.4.2 Corium International Business Overview
7.4.3 Corium International Transdermal and Transmucosal Drug Delivery Major Product Offerings
7.4.4 Corium International Transdermal and Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.4.5 Corium International Key News
7.5 DURECT
7.5.1 DURECT Corporate Summary
7.5.2 DURECT Business Overview
7.5.3 DURECT Transdermal and Transmucosal Drug Delivery Major Product Offerings
7.5.4 DURECT Transdermal and Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.5.5 DURECT Key News
7.6 Pantec Biosolutions
7.6.1 Pantec Biosolutions Corporate Summary
7.6.2 Pantec Biosolutions Business Overview
7.6.3 Pantec Biosolutions Transdermal and Transmucosal Drug Delivery Major Product Offerings
7.6.4 Pantec Biosolutions Transdermal and Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.6.5 Pantec Biosolutions Key News
7.7 Tapemark
7.7.1 Tapemark Corporate Summary
7.7.2 Tapemark Business Overview
7.7.3 Tapemark Transdermal and Transmucosal Drug Delivery Major Product Offerings
7.7.4 Tapemark Transdermal and Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.7.5 Tapemark Key News
7.8 Tesa Labtec
7.8.1 Tesa Labtec Corporate Summary
7.8.2 Tesa Labtec Business Overview
7.8.3 Tesa Labtec Transdermal and Transmucosal Drug Delivery Major Product Offerings
7.8.4 Tesa Labtec Transdermal and Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.8.5 Tesa Labtec Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Transdermal and Transmucosal Drug Delivery Market Opportunities & Trends in Global Market
Table 2. Transdermal and Transmucosal Drug Delivery Market Drivers in Global Market
Table 3. Transdermal and Transmucosal Drug Delivery Market Restraints in Global Market
Table 4. Key Players of Transdermal and Transmucosal Drug Delivery in Global Market
Table 5. Top Transdermal and Transmucosal Drug Delivery Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Transdermal and Transmucosal Drug Delivery Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Transdermal and Transmucosal Drug Delivery Revenue Share by Companies, 2017-2022
Table 8. Global Companies Transdermal and Transmucosal Drug Delivery Product Type
Table 9. List of Global Tier 1 Transdermal and Transmucosal Drug Delivery Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Transdermal and Transmucosal Drug Delivery Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Transdermal and Transmucosal Drug Delivery Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Transdermal and Transmucosal Drug Delivery Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Transdermal and Transmucosal Drug Delivery Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Transdermal and Transmucosal Drug Delivery Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Transdermal and Transmucosal Drug Delivery Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Transdermal and Transmucosal Drug Delivery Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 30. 3M Corporate Summary
Table 31. 3M Transdermal and Transmucosal Drug Delivery Product Offerings
Table 32. 3M Transdermal and Transmucosal Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 33. Antares Pharma Corporate Summary
Table 34. Antares Pharma Transdermal and Transmucosal Drug Delivery Product Offerings
Table 35. Antares Pharma Transdermal and Transmucosal Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 36. Aveva Drug Delivery Systems Corporate Summary
Table 37. Aveva Drug Delivery Systems Transdermal and Transmucosal Drug Delivery Product Offerings
Table 38. Aveva Drug Delivery Systems Transdermal and Transmucosal Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 39. Corium International Corporate Summary
Table 40. Corium International Transdermal and Transmucosal Drug Delivery Product Offerings
Table 41. Corium International Transdermal and Transmucosal Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 42. DURECT Corporate Summary
Table 43. DURECT Transdermal and Transmucosal Drug Delivery Product Offerings
Table 44. DURECT Transdermal and Transmucosal Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 45. Pantec Biosolutions Corporate Summary
Table 46. Pantec Biosolutions Transdermal and Transmucosal Drug Delivery Product Offerings
Table 47. Pantec Biosolutions Transdermal and Transmucosal Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 48. Tapemark Corporate Summary
Table 49. Tapemark Transdermal and Transmucosal Drug Delivery Product Offerings
Table 50. Tapemark Transdermal and Transmucosal Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 51. Tesa Labtec Corporate Summary
Table 52. Tesa Labtec Transdermal and Transmucosal Drug Delivery Product Offerings
Table 53. Tesa Labtec Transdermal and Transmucosal Drug Delivery Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Transdermal and Transmucosal Drug Delivery Segment by Type in 2021
Figure 2. Transdermal and Transmucosal Drug Delivery Segment by Application in 2021
Figure 3. Global Transdermal and Transmucosal Drug Delivery Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Transdermal and Transmucosal Drug Delivery Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Transdermal and Transmucosal Drug Delivery Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Transdermal and Transmucosal Drug Delivery Revenue in 2021
Figure 8. By Type - Global Transdermal and Transmucosal Drug Delivery Revenue Market Share, 2017-2028
Figure 9. By Application - Global Transdermal and Transmucosal Drug Delivery Revenue Market Share, 2017-2028
Figure 10. By Region - Global Transdermal and Transmucosal Drug Delivery Revenue Market Share, 2017-2028
Figure 11. By Country - North America Transdermal and Transmucosal Drug Delivery Revenue Market Share, 2017-2028
Figure 12. US Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Transdermal and Transmucosal Drug Delivery Revenue Market Share, 2017-2028
Figure 16. Germany Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 17. France Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Transdermal and Transmucosal Drug Delivery Revenue Market Share, 2017-2028
Figure 24. China Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 28. India Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Transdermal and Transmucosal Drug Delivery Revenue Market Share, 2017-2028
Figure 30. Brazil Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Transdermal and Transmucosal Drug Delivery Revenue Market Share, 2017-2028
Figure 33. Turkey Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 37. 3M Transdermal and Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Antares Pharma Transdermal and Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Aveva Drug Delivery Systems Transdermal and Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Corium International Transdermal and Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. DURECT Transdermal and Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Pantec Biosolutions Transdermal and Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Tapemark Transdermal and Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Tesa Labtec Transdermal and Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
